Skip to main content
. 2022 Sep 2;6(17):5152–5159. doi: 10.1182/bloodadvances.2022007905

Figure 2.

Figure 2.

Bone marrow NK cell expression of Ki67 in patients with NDMM and control subjects. Bone marrow CD3CD56+CD16+ NK cell Ki67 expression in NDMM and control subjects. Proportions of NK56bright and NK56dim subsets expressing Ki67 in bone marrow of patients with NDMM and control subjects are also shown. **P ≤ .01; ns, not significant.